MoneyWorks4Me

Godavari Drugs Board to consider Audited Annual Financial results

18 May 2013 Evaluate

Godavari Drugs has informed that a meeting of the Board of Directors of the Company will be held on May 30, 2013, to consider and approve the Audited Annual Financial results of the Company for the year ended March 31, 2013, and consider recommendation of dividend, if any along with the results of the quarter ended on March 31, 2013.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..